Recursion uses artificial intelligence to help advance drug discovery, which could be a massive opportunity in healthcare.

All these programs are just the tip of the iceberg, though. Once Recursion demonstrates that its AI platform can find drugs that make it all the way through the clinical testing and regulatory ...

Recursion Pharmaceuticals shows high cash burn, limited efficacy data, and unproven platform validation. Check out why RXRX ...

Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today it will provide business updates and report its third quarter 2025 ...

Bullish option flow detected in Recursion Pharmaceuticals (RXRX) with 35,100 calls trading, 5x expected, and implied vol increasing almost 42 ...

The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kongens Lyngby, Denmark ...

James Chen, CMT is an expert trader, investment adviser, and global market strategist. Gordon Scott has been an active investor and technical analyst or 20+ years. He is a Chartered Market Technician ...

Police are appealing for public help to find a man wanted in relation to multiple property and statutory offences.

Abstract: In recent years, the spotlight of research in the adaptive learning era has turned toward distributed adaptive filtering algorithms for sparse systems over ...

Abstract: We aimed to predict recurrence in lung cancer patients using PET radiomics features and machine learning algorithms. In this work, 136 non-small cell lung cancer (NSCLC) patients were ...